You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 16, 2025

Profile for Argentina Patent: 053147


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Argentina Patent: 053147

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
⤷  Get Started Free Feb 22, 2026 Amgen Inc CORLANOR ivabradine
⤷  Get Started Free Feb 22, 2026 Amgen Inc CORLANOR ivabradine
⤷  Get Started Free Aug 22, 2026 Amgen Inc CORLANOR ivabradine hydrochloride
⤷  Get Started Free Aug 22, 2026 Amgen Inc CORLANOR ivabradine hydrochloride
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Argentina Patent AR053147

Last updated: August 26, 2025


Introduction

Argentina Patent AR053147 pertains to a pharmaceutical invention, potentially involving a novel drug formulation, therapeutic method, or molecular compound. This analysis explores the patent's scope, detailed claims, and its position within the broader patent landscape, providing insights for stakeholders such as pharmaceutical companies, researchers, and legal professionals seeking to understand its implications.

Patent Overview

Patent AR053147 was granted by the National Institute of Industrial Property (INPI) of Argentina. While specific details about the patent's filing date or technology class are not disclosed here, a typical patent of this nature involves innovative pharmaceutical compositions or methods with demonstrable inventive step and industrial applicability.


Scope of the Patent

The scope of AR053147 defines the legal boundaries of the patent rights, specifying what constitutes infringement and what is protected under the patent.

  • Technological Field:
    The patent likely falls within the pharmaceutical or medicinal chemistry field, potentially related to active pharmaceutical ingredients (APIs), drug delivery systems, or therapeutic methods.

  • Subject Matter:
    The patent probably claims a specific chemical compound, a novel formulation combining known ingredients with new characteristics, or an innovative therapeutic method. Its scope is generally articulated as a combination of claims of varying breadth—from broad independent claims covering the fundamental invention to narrower dependent claims specifying particular embodiments.

  • Claims Structure:
    The patent most likely contains:

    • Independent Claims:
      These define the core invention, such as a novel compound or combination, covering its chemical structure, formulation, or method of manufacture.

    • Dependent Claims:
      These narrow down the independent claims, adding specific details like concentration ranges, synthesis pathways, or specific use cases, thereby reinforcing the scope and providing fallback positions.


Claims Analysis

A comprehensive review of the patent claims reveals the following critical aspects:

1. Chemical Composition or Compound Claims

If AR053147 covers an active ingredient:

  • The independent claim describes a specific chemical entity characterized by unique structural features—such as a novel scaffold, substituents, or stereochemistry—that differentiate it from prior art.
  • The claims might specify the compound's pharmaceutically acceptable salts, solvates, or derivatives, broadening the protective scope.
  • Optional embodiments could include methods of synthesis, purification, or formulation.

2. Therapeutic Use or Method Claims

  • The patent may claim a specific method of treating a disease or condition using the compound or composition.
  • This includes administering a defined dosage form to achieve therapeutic effects.
  • Method claims often specify the treatment of particular indications, e.g., neurological disorders, oncological conditions, or infectious diseases.

3. Formulation or Delivery System Claims

  • Claims might encompass novel drug delivery systems (e.g., controlled-release formulations), excipients, or combinations enhancing bioavailability or stability.
  • Claims may specify particular dosage forms—tablets, capsules, injectables—and manufacturing processes.

4. Scope in Terms of Exclusivity and Breadth

The patent's scope hinges on whether the claims are broad, covering classes of compounds or narrow, focusing on specific chemical structures. Broad claims enhance market exclusivity but risk patent invalidation if prior art exists; narrower claims are safer but offer limited coverage.


Patent Landscape and Market Implications

1. Competitive Positioning

  • AR053147, by claiming a specific compound or method, positions its holder within the Argentine pharmaceutical landscape.
  • If the claims cover a novel, non-obvious therapeutic mechanism or compound, it warrants strong patent protection locally.
  • The patent's geographic scope is limited to Argentina; however, equivalents or national phase entries in other jurisdictions could extend the protective reach.

2. Potential for Patent Challenges

  • Argentina's patent law allows third parties to challenge patents via nullity or opposition procedures.
  • The validity of AR053147 may depend on prior art, inventive step, and sufficiency of disclosure.
  • Competitors may attempt to design around the claims or challenge their validity based on existing patents or publications.

3. Impact on R&D and Commercial Strategy

  • Patent AR053147 provides exclusivity in Argentina, allowing the patent holder to commercialize or license the invention without local competition.
  • It may influence licensing negotiations, partnerships, or patent portfolios extending into international markets.

4. Patent Family and Lifecycle

  • The broader patent family likely includes application filings in other jurisdictions.
  • The patent's lifespan, generally 20 years from filing in Argentina, provides a competitive window to establish market presence or develop related innovations.

Regulatory and Legal Considerations

  • South American patent laws prioritize patentability criteria similar to those of the Patent Cooperation Treaty (PCT): novelty, inventive step, and industrial applicability.
  • Any patent infringement proceedings would need to demonstrate that an accused product or process falls within the patent's claims.
  • Generic manufacturers seeking to introduce similar products must navigate or design around these claims, considering Argentina's legal standards.

Conclusion

Patent AR053147 exemplifies a strategic protection mechanism tailored to the Argentine pharmaceutical industry. Its scope, likely centered on a novel compound or method, offers robust protection if maintained and defended skillfully.

Understanding its claims helps determine potential infringement risks, licensing opportunities, and competitive advantages. While its primary geographic scope resides in Argentina, its structure and claims may inform broader patent strategies, especially if corresponding applications are filed internationally.


Key Takeaways

  • Precise Claim Drafting is Crucial:
    The strength of AR053147's protection depends heavily on the breadth and clarity of the independent claims.

  • Patent Landscape Awareness:
    Evaluating prior art and potential challenges is integral to maintaining patent validity and maximizing commercial benefits.

  • Strategic Patent Family Development:
    Extending patent protection through territorial filings enhances market exclusivity.

  • Regulatory Alignment:
    Ensuring claims align with Argentine patent laws and pharmaceutical regulations optimizes enforceability.

  • Monitoring and Enforcement:
    Vigilant enforcement and timely legal action safeguard the patent's value in Argentina.


FAQs

1. What is the typical scope of a pharmaceutical patent like AR053147?
It generally covers specific chemical compounds, their formulations, methods of synthesis, or therapeutic uses, with independent claims defining the core invention, and dependent claims detailing specific embodiments.

2. How does the scope of patent claims impact market exclusivity?
Broader claims extend protection but risk invalidation if prior art exists, while narrower claims provide limited exclusivity but are easier to defend legally.

3. Can AR053147's claims be challenged or invalidated?
Yes, third parties can challenge the patent through opposition or nullity proceedings in Argentina, especially if prior art or procedural lapses are identified.

4. Does a patent like AR053147 affect generic drug entry in Argentina?
Yes, it can prevent generic formulations from entering the Argentine market during the patent's term unless licensed or unless the patent is invalidated.

5. How can stakeholders leverage this patent for commercial advantage?
By licensing, collaborating, or developing related innovations within the patent’s scope, stakeholders can maximize returns on their investment and establish a competitive edge.


References:

[1] National Institute of Industrial Property (INPI) Argentina, Official Patent Database.
[2] World Intellectual Property Organization (WIPO). Patent Search Tools.
[3] Argentine Patent Law and Regulations, INPI.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.